Română
Русский
English
0 Lei
Infoline and Appointments
84 00 00
bd. Negruzzi 4/2
MRI Prostate Cancer
     Prostate cancer - is a public health problem worldwide, being the most commonly detected cancer and the second leading cause of death among men.
     Visual assessment using magnetic resonance imaging (MRI) of the prostate gland is the most accurate and the only non-invasive method, the modern standard of patients management.

The main indications for MRI of the prostate are:
     • detection, localization and assessment of the prostate affection before biopsy.
     • differential exclusion between the benign and malignant affections in order to decrease the number of biopsies and processing.
     • active monitoring of cancer latent forms that do not affect the life time of a man.
     • detection of an extracapsular spread and invasion degree of the adjacent formations.
     • ranking the patients with the hystologically distinctive prostate cancer.
     • distant assessment of lymphadenopathies and metastases.  

     The MRI has major importance when: planning and establishing treatment modality (surgical, focal therapy, radiotherapy); high-precision post-therapeutic assessment  in order to reduce the number of biopsies; early postoperative assessment, which allows to detect complications and remaining damages as well as possible recurrences.
 

     Due to performance potential of the CDG equipment, the radiologist receives a detailed description of the pathological proliferative process of the prostate, in accordance with the PI-RADS standards used, in particular, in preparing the patient for a complex treatment.

     After assessment of the prostate through an integrated visualization protocol (which includes contrast dynamics and DWI), it comes with a grade from 1 to 5, where 1 – is most likely benign, and 5 - is a high suspicion of a malignant process.





2013 © COPYRIGHT CDG.
All rights reserved.
Infoline and Appointments
84 00 00
bd. Negruzzi 4/2
realizat de DQ Team